![](/img/cover-not-exists.png)
Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study
Matucci-Cerinic, Marco, Allanore, Yannick, Kavanaugh, Arthur, Buch, Maya H, Schulze-Koops, Hendrik, Kucharz, Eugeniusz J, Woehling, Heike, Babic, Goran, Poetzl, Johann, Davis, Adanna, Schwebig, ArndVolume:
4
Language:
english
Journal:
RMD Open
DOI:
10.1136/rmdopen-2018-000757
Date:
November, 2018
File:
PDF, 823 KB
english, 2018